Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED ASSAYS > 100 phenotypic and molecular assays for immediate performance or adaptation to specific cell types > Multiplexing, miniaturization, automation of cell-based assays > Assay development with the cellular model, readout, and high-content screening technology needed BIOMARKER ANALYSIS > Design and development of biomarker assays > Automated biomarker quantification in tissue sections and tissue microarrays (TMAs) > Biomarker analysis in whole blood by high-throughput flow cytometry Since 2003, Fluofarma has been supporting over 70 pharmaceutical companies in the dicovery of new therapeutic targets, compounds and biomarkers. To learn more about Fluofarma’s contract research services, please visit www.fluofarma.com
Looking for a particular Fluofarma employee's phone or email?
Fluofarma Questions
The Fluofarma annual revenue was $6 million in 2026.
Pierre Piazza is the Owner of Fluofarma.
1 people are employed at Fluofarma.
Fluofarma is based in Pessac, Wallis and Futuna.
The NAICS codes for Fluofarma are [541, 54171, 5417, 54, 541714].
The SIC codes for Fluofarma are [87, 873].
Top Fluofarma Employees
-
Pierre Piazza
Owner at Fluofarma
Bordeaux, FR
Related Companies
